AbCellera Biologics Inc. (ABCL) Operating income 2019–2025
AbCellera Biologics Inc. (ABCL) annual operating income history from SEC filings — each fiscal year as reported.
-$217.1MFY2025 · since FY2019: -$4.1M → -$217.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$217.1M | +31.0% |
| FY2024 | -$314.8M | -32.7% |
| FY2023 | -$237.2M | -209.6% |
| FY2022 | $216.5M | +5.9% |
| FY2021 | $204.4M | +31.0% |
| FY2020 | $156.0M | +3889.9% |
| FY2019 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice